No, Efudex (5-fluorouracil) Should Not Be Used for Seborrheic Keratosis
Efudex is FDA-approved specifically for actinic keratoses and superficial basal cell carcinomas, not for seborrheic keratoses, which are benign lesions with entirely different pathophysiology. 1
Why This Distinction Matters
Different Disease Processes
- Actinic keratoses are premalignant keratinocyte neoplasms arising from chronic UV damage with potential for progression to squamous cell carcinoma 2
- Seborrheic keratoses are benign epidermal growths with no malignant potential
- Fluorouracil works by interfering with DNA synthesis in rapidly dividing dysplastic cells 1, which is the mechanism relevant to treating premalignant lesions, not benign growths
FDA Labeling and Guidelines
The FDA label for Efudex explicitly states it is "recommended for the topical treatment of multiple actinic or solar keratoses" and superficial basal cell carcinomas 1. There is no mention of seborrheic keratoses as an indication.
Current AAD guidelines strongly recommend 5-fluorouracil for actinic keratoses 2, but these guidelines do not address seborrheic keratoses at all, as they are fundamentally different conditions.
Evidence for Seborrheic Keratosis Treatment
What Actually Works
A 2023 systematic review of topical treatments for seborrheic keratoses found that hydrogen peroxide showed the greatest evidence for clinical clearance 3. Other effective options included:
- Tazarotene 0.1% cream
- Trichloroacetic acid (65-80%)
- Diclofenac sodium solution
The Single Case Report Caveat
While one 1995 case report described successful treatment of a giant seborrheic keratosis with topical fluorouracil 4, a single case report from nearly 30 years ago does not constitute evidence for routine clinical use, especially when the FDA indication explicitly excludes this condition and better-studied alternatives exist.
Recommended Approach
For seborrheic keratoses, use first-line treatments:
- Cryotherapy
- Shave excision
- Topical hydrogen peroxide (if seeking non-invasive option)
These have established efficacy profiles specifically for seborrheic keratoses 3, unlike fluorouracil which lacks both FDA approval and quality evidence for this indication.
Clinical Pitfall to Avoid
Do not confuse actinic keratoses with seborrheic keratoses. While both may appear as scaly lesions in sun-exposed areas of older adults, actinic keratoses are rough, adherent, and premalignant, while seborrheic keratoses are waxy, "stuck-on" appearing, and benign. Misdiagnosis could lead to either inappropriate treatment or failure to treat a premalignant condition.